CAS 178600-20-9

(2E,4E,6E)-7-(3,5-Di-tert-butylphenyl)-3-methylocta-2,4,6-trienoic acid

Description:

The chemical substance known as (2E,4E,6E)-7-(3,5-Di-tert-butylphenyl)-3-methylocta-2,4,6-trienoic acid, with the CAS number 178600-20-9, is a synthetic organic compound characterized by its complex structure featuring multiple double bonds and a branched alkyl group. This compound belongs to the class of trienoic acids, which are characterized by the presence of three conjugated double bonds in their carbon chain. The presence of the bulky 3,5-di-tert-butylphenyl group contributes to its hydrophobic nature and may influence its solubility and reactivity. The compound is likely to exhibit interesting biological activities due to its structural features, making it a subject of interest in fields such as medicinal chemistry and materials science. Its unique configuration may also affect its optical properties and stability under various conditions. Overall, this compound's distinct characteristics make it a valuable candidate for further research and potential applications in various chemical and pharmaceutical industries.

Formula: C₂₃H₃₂O₂

Synonyms:

• Lgd-1550
• Alrt-550
• Alrt-1550
• Lg-1550

2,4,6-Octatrienoic acid, 7-[3,5-bis(1,1-dimethylethyl)phenyl]-3-methyl-, (2E,4E,6E)-

CAS: 178600-20-9

Formula: C₂₃H₃₂O₂

Molecular weight: 340.499

Ref: IN-DA002663

LGD-1550 = ALRT-1550

CAS: 178600-20-9

LGD-1550 is a novel, orally active and potent small molecule that binds to all-trans retinoic acid receptors (RARs) and activates the expression of genes involved in cell growth, differentiation, and apoptosis. It has been shown to be effective against various types of cancer including squamous carcinoma, cervical cancer, and multidrug resistant cancers. LGD-1550 has been shown to have potent antitumor activity in animal models of breast cancer, prostate cancer, and melanoma. In these studies, LGD-1550 was administered orally with no observed systemic toxicity.

Purity: Min. 95%

Ref: 3D-BL177434

ALRT 1550

CAS: 178600-20-9

ALRT 1550, a retinoic acid agent (RAR) agonist, is used potentially for the treatment of cervical carcinoma.

Formula: C₂₃H₃₂O₂

Color and Shape: Solid

Molecular weight: 340.5

Ref: TM-T26601